IDDI at Outsourcing in Clinical Trials DACH 2022
November 30, 2022 — December 1, 2022
Meet IDDI team at Outsourcing in Clinical Trials DACH!
Schedule a meeting with Erik Falvey, IDDI’s Sr. Director Business Development Europe at this year’s OCT DACH to discuss how IDDI can help deliver successful clinical trials for your next oncology drug development projects!
IDDI is an oncology CRO led by a highly-skilled biostatistical and eclinical team of thought-leaders in oncology research and have supported 800+ oncology studies to date.
We have designed, collected, analyzed clinical data and reported on oncology clinical trials for more than 30 years and are currently collaborating with oncology cooperative groups all over the world.LEARN MORE
About OCT DACH 2022:
The two-day OCT DACH will focus upon the operational challenges in clinical development found within Germany, Austria and Switzerland. Delegates will discuss the common challenges and trends impacting the region, including steps for defining contractual relationships and getting the maximum from external providers, incentivizing good relationships with CROs and constructing defined deadlines.